European Commission Approves GW Pharmaceuticals Plc (NASDAQ:GWPH)’s Epidyolex To Treat Seizures In Patients With TSC
European Commission approved Epidyolex of GW Pharmaceuticals Plc (NASDAQ:GWPH) to cure seizures associated with TSC patients aged two years and
Read more